View in EDS

Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines.

Saved in:
Bibliographic Details
Title: Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines.
Authors: Brennan RJ; Sanofi, Cambridge, MA, USA. richbrennan@gmail.com., Jenkinson S; Pfizer, La Jolla, CA, USA.; Metrion Biosciences, San Diego, CA, USA., Brown A; GSK, Stevenage, UK., Delaunois A; UCB Biopharma, Braine-l'Alleud, Belgium., Dumotier B; Novartis Biomedical Research, Basel, Switzerland., Pannirselvam M; Vertex Pharmaceuticals, Boston, MA, USA.; GSK, Waltham, MA, USA., Rao M; Janssen Research & Development, San Diego, CA, USA.; Neurocrine Biosciences, San Diego, CA, USA., Ribeiro LR; UCB Biopharma, Braine-l'Alleud, Belgium.; AstraZeneca, Cambridge, UK.; Grunenthal, Berkshire, UK., Schmidt F; Sanofi, Frankfurt, Germany., Sibony A; UCB Biopharma, Braine-l'Alleud, Belgium., Timsit Y; Novartis Biomedical Research, Cambridge, MA, USA.; Blueprint Medicines, Cambridge, MA, USA., Sales VT; Takeda Pharmaceuticals, Cambridge, MA, USA., Armstrong D; Novartis Biomedical Research, Cambridge, MA, USA.; Armstrong Pharmacology, Macclesfield, UK., Lagrutta A; Merck, North Wales, PA, USA., Mittlestadt SW; AbbVie, North Chicago, IL, USA., Naven R; Takeda Pharmaceuticals, Cambridge, MA, USA.; Novartis Biomedical Research, Cambridge, MA, USA., Peri R; Takeda Pharmaceuticals, Cambridge, MA, USA.; Alexion Pharmaceuticals, Wilmington, DE, USA., Roberts S; Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland., Vergis JM; Faegre Drinker Biddle and Reath, LLP, Washington, DC, USA., Valentin JP; UCB Biopharma, Braine-l'Alleud, Belgium.
Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Jul; Vol. 23 (7), pp. 563.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784 (Electronic) Linking ISSN: 14741776 NLM ISO Abbreviation: Nat Rev Drug Discov Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38886593
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Brennan+RJ%22">Brennan RJ</searchLink>; Sanofi, Cambridge, MA, USA. richbrennan@gmail.com.<br /><searchLink fieldCode="AU" term="%22Jenkinson+S%22">Jenkinson S</searchLink>; Pfizer, La Jolla, CA, USA.; Metrion Biosciences, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Brown+A%22">Brown A</searchLink>; GSK, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Delaunois+A%22">Delaunois A</searchLink>; UCB Biopharma, Braine-l'Alleud, Belgium.<br /><searchLink fieldCode="AU" term="%22Dumotier+B%22">Dumotier B</searchLink>; Novartis Biomedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pannirselvam+M%22">Pannirselvam M</searchLink>; Vertex Pharmaceuticals, Boston, MA, USA.; GSK, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rao+M%22">Rao M</searchLink>; Janssen Research & Development, San Diego, CA, USA.; Neurocrine Biosciences, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ribeiro+LR%22">Ribeiro LR</searchLink>; UCB Biopharma, Braine-l'Alleud, Belgium.; AstraZeneca, Cambridge, UK.; Grunenthal, Berkshire, UK.<br /><searchLink fieldCode="AU" term="%22Schmidt+F%22">Schmidt F</searchLink>; Sanofi, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Sibony+A%22">Sibony A</searchLink>; UCB Biopharma, Braine-l'Alleud, Belgium.<br /><searchLink fieldCode="AU" term="%22Timsit+Y%22">Timsit Y</searchLink>; Novartis Biomedical Research, Cambridge, MA, USA.; Blueprint Medicines, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sales+VT%22">Sales VT</searchLink>; Takeda Pharmaceuticals, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+D%22">Armstrong D</searchLink>; Novartis Biomedical Research, Cambridge, MA, USA.; Armstrong Pharmacology, Macclesfield, UK.<br /><searchLink fieldCode="AU" term="%22Lagrutta+A%22">Lagrutta A</searchLink>; Merck, North Wales, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mittlestadt+SW%22">Mittlestadt SW</searchLink>; AbbVie, North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Naven+R%22">Naven R</searchLink>; Takeda Pharmaceuticals, Cambridge, MA, USA.; Novartis Biomedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Peri+R%22">Peri R</searchLink>; Takeda Pharmaceuticals, Cambridge, MA, USA.; Alexion Pharmaceuticals, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Roberts+S%22">Roberts S</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vergis+JM%22">Vergis JM</searchLink>; Faegre Drinker Biddle and Reath, LLP, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Valentin+JP%22">Valentin JP</searchLink>; UCB Biopharma, Braine-l'Alleud, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101124171%22">Nature reviews. Drug discovery</searchLink> [Nat Rev Drug Discov] 2024 Jul; Vol. 23 (7), pp. 563.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101124171 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-1784 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214741776%22">14741776 </searchLink><i>NLM ISO Abbreviation: </i>Nat Rev Drug Discov <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38886593
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41573-024-00993-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 563
    Titles:
      – TitleFull: Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brennan RJ
      – PersonEntity:
          Name:
            NameFull: Jenkinson S
      – PersonEntity:
          Name:
            NameFull: Brown A
      – PersonEntity:
          Name:
            NameFull: Delaunois A
      – PersonEntity:
          Name:
            NameFull: Dumotier B
      – PersonEntity:
          Name:
            NameFull: Pannirselvam M
      – PersonEntity:
          Name:
            NameFull: Rao M
      – PersonEntity:
          Name:
            NameFull: Ribeiro LR
      – PersonEntity:
          Name:
            NameFull: Schmidt F
      – PersonEntity:
          Name:
            NameFull: Sibony A
      – PersonEntity:
          Name:
            NameFull: Timsit Y
      – PersonEntity:
          Name:
            NameFull: Sales VT
      – PersonEntity:
          Name:
            NameFull: Armstrong D
      – PersonEntity:
          Name:
            NameFull: Lagrutta A
      – PersonEntity:
          Name:
            NameFull: Mittlestadt SW
      – PersonEntity:
          Name:
            NameFull: Naven R
      – PersonEntity:
          Name:
            NameFull: Peri R
      – PersonEntity:
          Name:
            NameFull: Roberts S
      – PersonEntity:
          Name:
            NameFull: Vergis JM
      – PersonEntity:
          Name:
            NameFull: Valentin JP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2024 Jul
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1474-1784
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Nature reviews. Drug discovery
              Type: main
ResultId 1